Cargando…
Stem cell therapy for diabetes mellitus
In this review, we present (1) a brief discussion of hematopoietic stem cell transplantation (HSCT) for severe and refractory autoimmune diseases (AIDs) from its beginning in 1996 through recently initiated prospective randomized clinical trials; (2) an update (up to July 2009) of clinical and labor...
Autores principales: | Voltarelli, Júlio C, Couri, Carlos E B, Oliveira, Maria C, Moraes, Daniela A, Stracieri, Ana B P L, Pieroni, Fabiano, Barros, George M N, Malmegrim, Kelen C R, Simões, Belinda P, Leal, Angela M O, Foss, Milton C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089753/ https://www.ncbi.nlm.nih.gov/pubmed/25018908 http://dx.doi.org/10.1038/kisup.2011.22 |
Ejemplares similares
-
Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
por: Malmegrim, Kelen C. R., et al.
Publicado: (2017) -
New Horizons in the Treatment of Type 1 Diabetes: More Intense Immunosuppression and Beta Cell Replacement
por: Couri, Carlos E. B., et al.
Publicado: (2018) -
Stem cell transplantation for type 1 diabetes mellitus
por: Voltarelli, Júlio C, et al.
Publicado: (2009) -
Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties
por: Yaochite, Juliana Navarro Ueda, et al.
Publicado: (2016) -
Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients
por: de Lima, Kalil A., et al.
Publicado: (2016)